Azitra (NYSEAMERICAN:AZTR) Shares Down 1.1%

Azitra, Inc. (NYSEAMERICAN:AZTR) was down 1.1% on Friday . The company traded as low as $0.55 and last traded at $0.55. Approximately 111,676 shares changed hands during trading, a decline of 89% from the average daily volume of 1,012,930 shares. The stock had previously closed at $0.56.

Azitra Trading Down 1.1 %

The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 0.01.

Azitra (NYSEAMERICAN:AZTR) last posted its earnings results on Monday, August 12th. The company reported ($2.74) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($2.59) by ($0.15). Azitra had a negative net margin of 1,644.90% and a negative return on equity of 278.76%. The business had revenue of $0.01 million during the quarter. Sell-side analysts forecast that Azitra, Inc. will post -3.06 EPS for the current fiscal year.

About Azitra

Azitra, Inc, an early-stage biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease.